Debt Conversion and Interest Payment Agreement Sample Contracts

DEBT CONVERSION AND INTEREST PAYMENT AGREEMENT

Debt Conversion and Interest Payment Agreement • March 24th, 2025 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Debt Conversion and Interest Payment Agreement
• Filed
  March 24th, 2025
• Company
  Aptose Biosciences Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Debt Conversion and Interest Payment Agreement (this “Agreement”), dated March 18, 2025 (the “Effective Date”), is entered into by and between Aptose Biosciences Inc., a corporation incorporated pursuant to the Canada Business Corporations Act (the “Company”), and Hanmi Pharmaceutical Co., Ltd. (the “Lender”), a corporation incorporated under the laws of the Republic of Korea. The Company and the Lender are sometimes referred to herein individually as a “Party” and together as the “Parties.”